Aortic Arch Related Cerebral Hazard Trial (ARCH)

计划入组 350 人 · 首次发布于 2005 年 10 月 10 日

Aortic Arch Reconstruction

计划入组 36 人 · 首次发布于 2006 年 1 月 18 日

Screw Retained Arch Bar Versus Conventional Erich's Arch Bar in Maxillomandibular Fixation

计划入组 20 人 · 首次发布于 2022 年 6 月 2 日

Interferon alpha-2a biosimilar(Biopartners GmbH)

ARC2-001

ARCT-032

Arch Biopartners Inc.

Canada

BioPartners GmbH

Germany

Arch Therapeutics, Inc.

United States

Arch Biopartners Establishes Australian Subsidiary for Metablok Phase I Trial in Acute Kidney Injury

Arch Biopartners Initiates Phase II Trial of LSALT Peptide for Cardiac Surgery-Associated Acute Kidney Injury

Arch Biopartners Secures $600,000 CAD to Advance Kidney Disease Drug Development